Seeing Beyond Pixels

For Better Diagnosis. For Better Drug Development.


Our partners depend on the information in bio- and medical images to advance scientific research, to shorten drug development timeline and to improve diagnostic accuracy for better patient care. They come to Keen Eye for tools to improve their productivity and outcome, and to uncover insights and meanings out of huge amounts of data. Learn more here about how Keen Eye’s team of data scientists create AI-powered applications to give them a competitive edge to get ahead.

Pharma / Biotech Drug Development

Find insights in tissue images to accelerate drug development

Whether you want to confirm disease progression or to stratify patients, outsource your biomarker quantification and discovery projects to digital pathology machine learning experts at Keen Eye. We accompany you from research to clinical trials to help reduce your pipeline risks with our regulatory-ready applications.

Contract Research Organizations

Reduce costs and promote standardization

As a CRO providing services to pharma drug development, you need access to the latest technology to be competitive. Keen Eye’s cutting edge AI applications for image analysis deliver fast and reproducible biomarker quantification to improve your productivity and bottomline.

Diagnostic Companies

Offer AI solutions to grow your topline

You don’t need to start from scratch when you want to improve your products and services, or expand your reach to a wider market with new offerings using Artificial Intelligence. Tap into Keen Eye’s innovative deep learning engine and the team of data scientists to rapidly develop proprietary AI-powered solutions. Our licensing model takes the risk out of adopting new technology.

Partners who choose Keen Eye

idv logo
logo cilcare 2014